Novartis Investigative Site

Ouest-Montreal H2W1R7

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Familial Chylomicronemia Syndrome (FCS), Familial Chylomicronemia Syndrome (FCS) (HLP Type I), Type 2 Diabetes Mellitus

Studies at this site

• Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. — Stopped early
• A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early